2021
Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis
Ward Z, Stone J, Bishop C, Ivakin V, Eritsyan K, Deryabina A, Low A, Cepeda J, Kelly SL, Heimer R, Cook R, Altice FL, Litz T, Terlikbayeva A, El-Bassel N, Havarkov D, Fisenka A, Boshnakova A, Klepikov A, Saliuk T, Deshko T, Vickerman P. Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis. The Lancet HIV 2021, 9: e42-e53. PMID: 34895484, PMCID: PMC8762142, DOI: 10.1016/s2352-3018(21)00274-5.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyAgonist therapyAntiretroviral therapyPublic health approachHIV transmissionDrug useDynamic HIV transmission modelHealth approachIncremental cost-effectiveness ratioHIV transmission modelNational InstituteCost-effectiveness ratioCountry-specific costsHIV incidenceUNAIDS 90US National InstitutesART coverageWHO targetPWIDTherapyPay thresholdsInfectious diseasesCost savingsDrug abuseIncremental cost
2019
HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy
LaMonaca K, Dumchev K, Dvoriak S, Azbel L, Morozova O, Altice FL. HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy. Current Psychiatry Reports 2019, 21: 47. PMID: 31161306, PMCID: PMC6685549, DOI: 10.1007/s11920-019-1038-8.Peer-Reviewed Original ResearchConceptsOpioid agonist therapySyringe services programDrug injectionAntiretroviral therapyHIV epidemicEvidence-based HIV prevention strategiesNew HIV casesHIV prevention strategiesHarm reduction programsAgonist therapyHIV incidenceHIV casesRecent FindingsThoughPrevention strategiesSexual partnersHIVInjectionTherapyReduction programsEpidemicPunitive drug lawsService programsMortalityCliniciansIncidence
2013
A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment
Vagenas P, Azbel L, Polonsky M, Kerimi N, Mamyrov M, Dvoryak S, Altice FL. A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment. Drug And Alcohol Dependence 2013, 132: s25-s31. PMID: 23932844, PMCID: PMC3825758, DOI: 10.1016/j.drugalcdep.2013.07.010.Peer-Reviewed Original ResearchConceptsOpioid substitution therapyDrug-related health problemsHIV preventionHealth problemsHIV sentinel surveillanceHIV prevention interventionsConcentration of HIVHIV incidenceHIV casesSubstitution therapyHIV prevalenceSentinel surveillancePrevention interventionsRisk populationsDisease RegistryTreatment servicesHealth reportingSubstance useHealthcare servicesRecent dataPrevalenceCrucial interventionPreventionInterventionOnline databases